These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8037103)

  • 1. Dose-response study of intravenous torsemide in congestive heart failure.
    Hariman RJ; Bremner S; Louie EK; Rogers WJ; Kostis JB; Nocero MA; Jones JP
    Am Heart J; 1994 Aug; 128(2):352-7. PubMed ID: 8037103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.
    Patterson JH; Adams KF; Applefeld MM; Corder CN; Masse BR
    Pharmacotherapy; 1994; 14(5):514-21. PubMed ID: 7997385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-week study of torsemide in patients with congestive heart failure.
    Goebel KM
    Clin Ther; 1993; 15(6):1051-9. PubMed ID: 8111802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
    Noe LL; Vreeland MG; Pezzella SM; Trotter JP
    Clin Ther; 1999 May; 21(5):854-66. PubMed ID: 10397380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure.
    Kramer WG; Smith WB; Ferguson J; Serpas T; Grant AG; Black PK; Brater DC
    J Clin Pharmacol; 1996 Mar; 36(3):265-70. PubMed ID: 8690821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacodynamics of torsemide in patients with congestive heart failure.
    Vargo D; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):48-54. PubMed ID: 8033494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
    Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
    Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
    Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Peddle GD; Singletary GE; Reynolds CA; Trafny DJ; Machen MC; Oyama MA
    J Vet Cardiol; 2012 Mar; 14(1):253-9. PubMed ID: 22364690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intravenous piretanide and furosemide in patients with congestive heart failure.
    Marsh JD; Nesto R; Glynn MA; Smith TW
    J Cardiovasc Pharmacol; 1982; 4(6):949-54. PubMed ID: 6185787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
    Murray MD; Deer MM; Ferguson JA; Dexter PR; Bennett SJ; Perkins SM; Smith FE; Lane KA; Adams LD; Tierney WM; Brater DC
    Am J Med; 2001 Nov; 111(7):513-20. PubMed ID: 11705426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA; Peddle GD; Reynolds CA; Singletary GE
    J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
    Vasavada N; Saha C; Agarwal R
    Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
    Gottlieb SS; Khatta M; Wentworth D; Roffman D; Fisher ML; Kramer WG
    Am J Med; 1998 Jun; 104(6):533-8. PubMed ID: 9674715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torasemide in chronic heart failure: results of the TORIC study.
    Cosín J; Díez J;
    Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.